Cite

HARVARD Citation

    Hartl, L. et al. (2022). Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease. Hepatology. 76 (6), pp. 1563-1575. [Online]. 
  
Back to record